Skip to main content

Company News

  • October 27, 2022

    20 years of collaboration in the fight against infectious diseases.

    For 20 years, bioMérieux and the Hospices Civils de Lyon (HCL) have been collaborating in an innovative public/private research partnership. Joined in 2016 by Claude Bernard Lyon 1 University, the three institutions are working to figure out the mechanisms of immunity in order to develop diagnostic tests.
  • October 24, 2022

    bioMérieux and Jackson Family Wines Introduce Groundbreaking Innovation for Wine Quality — BOTTLESAFE™

    bioMérieux, a world leader in in vitro diagnostics for more than 55 years, and Jackson Family Wines, the global, family-owned wine company based in Sonoma County, California, are pleased to announce the worldwide availability of BOTTLESAFE™.

  • July 08, 2022

    U.S. Department of Agriculture (USDA) Awards bioMérieux Innovation

    bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce the incorporation of the company’s innovative GENE-UP® QUANT Salmonella assay into the methodology used by the USDA Food Safety Inspection Service regional laboratories. 

  • May 05, 2022

    bioMérieux Wins 2022 Food Safety Innovation Award

    bioMérieux, a world leader in the field of in vitro diagnostics, has won the 2022 Food Safety Innovation Award for Predictive Diagnostics from theInternational Association for Food Protection (IAFP).

  • April 01, 2022

    bioMérieux Introduces Groundbreaking Innovation With GENE-UP® QUANT SALMONELLA

    bioMérieux, a world leader in the field of in vitro diagnostics since 1963, announces the launch of GENE-UP® QUANT Salmonella, the first, and only, AOAC approved true non-enrichment quantification diagnostic for Salmonella.

Follow us on Socials for more news!